FDA Inspection 789037 — Pfizer, Inc.
The FDA completed an inspection of Pfizer, Inc. on May 7, 2012 in Groton, CT. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 7, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Groton, CT (United States)
Additional Details
Sponsor, Contract Research Organization